Aims This study aimed to investigate whether an established behavioural intervention, Walking Away from Type 2 Diabetes, is effective at promoting and sustaining increased walking activity when delivered within primary care.
Introduction
Physical activity has consistently been shown to have a powerful therapeutic effect on glycaemic control in those with prediabetes and Type 2 diabetes mellitus [1, 2] , with randomized controlled trials (RCTs) showing that physical activity interventions slow progression to Type 2 diabetes mellitus in those with impaired glucose tolerance to similar levels as multi-faceted lifestyle interventions [2] . Observational research has also shown that moderate-intensity physical activity, such as walking, is associated with a reduced risk of Type 2 diabetes mellitus and cardiovascular disease [3, 4] . However, few studies have evaluated the implementation and translation of evidence-based physical activity interventions in 'real-world' contexts in the prevention or management of Type 2 diabetes mellitus [5, 6] .
In the Prediabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) study, we demonstrated that a 3-h group-based structured education programme could be effectively combined with pedometer use to increase walking activity in those with impaired glucose tolerance [7, 8] . The intervention used in the PREPARE trial was subsequently developed into the Walking Away from Type 2 Diabetes programme through adapting the content for a broader range of high-risk populations beyond impaired glucose tolerance and developing an educator training and quality assurance pathway to enable delivery within primary care. Walking Away was subsequently commissioned into routine primary care pathways within regions of the United Kingdom as a low-resource prevention programme. The aim of this study was to undertake a cluster trial to investigate the extent to which the results from the PREPARE trial can be replicated at 12 months when delivered within general practices to those with a high risk of Type 2 diabetes mellitus identified using an evidence-based non-invasive risk score [9] , and whether results are maintained at 24 and 36 months with annual group-based follow-on support.
Methods

Study design
The study is a clustered RCT; the full protocol has been published previously [10] . Follow-up measurements were assessed at 12 months after baseline, with maintenance assessed at 24 and 36 months. The study was coordinated from the Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust.
Participants
Ten general practices were recruited from Leicestershire (UK) across urban and rural locations. Practices were recruited by dissemination at local diabetes training events, emailed invitations and presentations at practice meetings. Within practices, participants at risk of Type 2 diabetes mellitus were identified using the Leicester Practice Risk Score [9] . Individuals between 18 and 74 years of age inclusive and above the 90th percentile of the calculated risk score were invited to take part [11] . All individuals with a high risk score were considered for inclusion, including those without dysglycaemia. Identified individuals were sent a letter of invitation and a patient information sheet by a member of their general practice. Individuals were not invited to take part if they were currently taking steroids because of potential confounding endocrinological effects, had a terminal illness or were unable to take part in any walking activity.
Ethics
National Health Service (NHS) ethical approval was granted for this project and all participants gave informed consent. The trial was sponsored by the University Hospitals of Leicester NHS Trust who were responsible for the conduct of the research.
Randomization
Randomization was conducted at the level of the general practice by an independent statistician employing a random number generator; a blocked design stratified for practice size was used. Practices were randomized after recruitment and baseline measures (1:1) to receive control conditions or Walking Away from Type 2 Diabetes Mellitus. Practices were enrolled and assigned to their randomized group by a project manager. Those collecting and processing data were blinded to allocation.
Procedures
Control
Control participants received a standardized booklet detailing information on Type 2 diabetes mellitus risk informed by Leventhal's common sense model and how physical activity and lifestyle change can be used to prevent or delay the disease [10] .
Intervention
The intervention group were offered the 3-h Walking Away from Type 2 Diabetes Mellitus group-based structured educational programme (henceforth referred to as Walking Away), described in detail previously [10] . Walking Away is based on an approach that has been shown to be effective at promoting increased ambulatory activity in those with impaired glucose tolerance [7, 8] , but adapted for a broader range of high-risk individuals and with a fully developed educator training and quality assurance pathway. Educators were recruited through advertisement and were registered healthcare professionals or had a relevant degree or occupation. Educators worked in pairs and delivered the intervention in recruited general practices, local hospitals and community settings such as church halls.
What's new?
• Walking Away from Type 2 Diabetes is an established low-resource behavioural intervention for those with a high risk of Type 2 diabetes mellitus that combines pedometer use with structured education.
• The longer term effectiveness of Walking Away was previously unknown.
• Using a cluster randomized controlled trial involving 808 high-risk individuals, we found modest increases in walking activity of 411 steps/day at 12 months in those receiving Walking Away compared to control conditions; however, results were not sustained over the longer term (36 months).
• This study further suggests that behavioural interventions with good evidence of efficacy are difficult to replicate when translated into a primary care setting.
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All participants in the intervention group were invited to attend two follow-on group-based sessions at 12 and 24 months, designed to reinforce the content of Walking Away, review progress, support the maintenance of behaviour change and discuss reasons for relapse. Each follow-up refresher session lasted 2 h and was conducted by a single educator. Participants also received short telephone contact (around 15 min) between annual sessions (at 6, 18 and 30 months) to provide further support.
Outcomes
Physical activity
Change in total ambulatory activity (steps/day) at the individual level after 12 months was assigned a priori as the primary outcome, with maintenance assessed at 24 and 36 months. Ambulatory activity was measured by accelerometer (GT3X, Actigraph, Pensacola, FL, USA). Participants were asked to wear the accelerometer, fitted on their trunks (placed on the right anterior axillary line) with a waistband, for seven consecutive days during waking hours. Data were integrated into 60-s epochs. Ambulatory activity was defined as: total ambulatory activity (primary outcome) -the average number of all accumulated steps per day; and purposeful ambulatory activity (secondary outcome) -the average number of accumulated steps per day undertaken above an intensity threshold (≥ 500 count/min) distinguishing steps accumulated in incidental activity from those involving more purposeful walking [12] . Time spent sedentary (< 100 count/min), in moderate-to vigorous-intensity (≥ 1952 count/min) and total physical activity (average count/day) were calculated [13] . At least four valid days of data were required for inclusion, with a valid day defined as at least 10 h of accelerometer wear time (non-wear defined as 60 min or more of continues zero counts). Outcomes were standardized to average daily values by dividing the total accumulated data over all valid days by the number of valid days. Data were processed through a bespoke computer programme (KineSoft version 3.3.76, KineSoft, New Brunswick, Canada; www.kinesoft.org).
Self-reported physical activity and sitting time were also measured using the short last-seven-days self-administered International Physical Activity Questionnaire (IPAQ); results were weighted my metabolic equivalents (METS) for walking (3.3 METS), moderate intensity (4 METS), vigorous intensity (8 METS) activities and summed to give total physical activity [14] .
Other secondary outcomes
Biochemical variables
Participants were invited to attend each clinical measurement session after a 12-h fast and 24 h of avoiding vigorousintensity exercise. Each measurement session involved an oral glucose tolerance test (OGTT) to assess fasting and 2-h post-challenge glucose values. HbA 1c and lipid profile (triglycerides, HDL-and total cholesterol) were also assessed. Analysis was conducted in the same clinical laboratory located within Leicester Royal Infirmary, UK, using stable methodology standardized to external quality assurance reference values.
Those who had a fasting, 2-h blood glucose or HbA 1c (from 2011 onwards) level in the diabetes range at any clinical measurement session were called back for a confirmatory OGTT [15, 16] . Those found to have Type 2 diabetes mellitus at baseline were excluded; those found to have Type 2 diabetes mellitus during the study were referred to routine clinical care.
Other anthropometric, demographic lifestyle and psychological variables
Arterial blood pressure was measured in the sitting position (Omron Healthcare, Henfield, UK); three measurements were obtained and the average of the last two measurements was used. Body weight, waist circumference (midpoint between the lower costal margin and iliac crest) and height were also measured. Information on current smoking status, medication history and ethnicity were obtained by interview. Social deprivation was determined by assigning an Index of Multiple Deprivation score to participant postcodes.
Diet was measured using the Dietary Instrument for Nutrition Education food frequency questionnaire, which provides a unitless score for total fat, unsaturated fat and fibre intake [17] . Health-related quality of life [18, 19] , depression and anxiety [19] and illness perceptions (for a high risk of Type 2 diabetes mellitus status) were also assessed [20] .
Statistical analysis
In order to detect a difference of 2000 steps/day between groups at 12 months [8] , assuming a standard deviation of 4000 steps/day [10] , a power of 90%, a significance of 0.05, an average cluster size of 90 and an intracluster correlation coefficient of 0.02 [10] , we required a minimum of eight clusters. In order to account for potential dropout at the cluster level and comply with guidance for minimum cluster numbers [21] , 10 general practice clusters were recruited.
A statistical analysis plan was written, finalized and agreed before data were available.
Participants were analysed in the groups to which they were assigned. Continuous outcomes were analysed using generalized estimating equation models with an exchangeable correlation structure, which adjusted for clustering. Missing data were not replaced. Outcomes were assessed at each time point along with a derived average over all three time points, thus both the cumulative and overall effect are provided.
Participants found to have developed Type 2 diabetes mellitus at their 12-month measurement visit (n = 19) were withdrawn after the primary measurement was completed; these individuals had their 24-and 36-month data imputed by carrying forward their 12-month results. Similarly, those diagnosed with Type 2 diabetes mellitus at 24 months (n = 28) were withdrawn and had their values carried forward for the 36-month analysis. This method has been used previously [8] .
Post-hoc analyses for the primary outcome were stratified by the presence or absence of any form of dysglycaemia at baseline [impaired glucose tolerance or impaired fasting glucose or HbA 1c ≥ 42 mmol/mol (6.0%)] to allow an assessment of the impact of elevated glucose (dysglycaemia) on behaviour change. Sensitivity analyses were carried out for total ambulatory activity at 12 and 36 months. The analysis was repeated when: (i) excluding those from the intervention group who did not attend the initial Walking Away education session and the two annual refresher sessions (per protocol); and (ii) intention to treat imputing any missing values using the command MI in Stata. Sensitivity and stratified analysis was not undertaken for secondary outcomes to avoid multiple comparisons. Adjustments were not made for multiple testing. Statistical significance was set at 5%. All analyses were conducted using Stata v. 13.
Results
The flow of the participants is highlighted in Fig. 1 . Ten practices were recruited to the study; five randomized to intervention, five to control. Practice recruitment commenced in November 2009 and patient recruitment in January 2010. Participant recruitment was complete in January 2011 and data collection in January 2014. No clusters withdrew from the study. Overall 833 participants were recruited, 25 of whom were excluded at baseline because they were diagnosed with Type 2 diabetes mellitus, leaving 808 within the trial. The median number of recruited participants per practice was 83 (range 47-127). In total, 696 (86%) participants attended 12-month follow-up, 571 (71%) of whom had valid accelerometer data across both baseline and 12-month follow-up. Missing accelerometer data was due to non-compliance with daily wear. Compared with those with available data for the primary outcome, those with missing data were more likely to be younger (61 vs. 64 years), come from more deprived areas (Index of Multiple Deprivation score 17.5 vs. 13.0), have a higher BMI (33.9 vs. 32.0 kg/m 2 ) and be less active (5910 vs. 6752 steps/ day). The baseline characteristics of the sample, stratified by intervention group are displayed in Table 1 . Groups were generally well matched, but those in the intervention group had substantially higher levels of social deprivation (Index of Multiple Deprivation score 18.7 vs. 9.8).
Of those randomized to the intervention, 325 (77%) attended the initial Walking Away programme, 248 (59%) attended Walking Away and at least one refresher session and 172 (41%) attended Walking Away and the two available refresher sessions. The characteristics of those that did and did not attend Walking Away are shown in Table S1 ; those that failed to attend had higher levels of BMI, waist circumference and smoking with lower levels of HDLcholesterol; there was also a trend towards higher levels of deprivation (P = 0.056). Table 2 displays the results at each time point and the average effect across all time points for the accelerometer variables. There was an increase in ambulatory activity of 411 steps/day [95% confidence interval (CI): 117, 704] in the intervention group compared with control at 12 months. The intracluster correlation coefficient for the primary outcome was 0.004 (95% CI: 0.000 to 0.023). Over the course of the study, there was a gradual decline in daily total ambulatory activity in both groups with no difference between groups by 36 months. The same pattern of results was observed for purposeful ambulatory activity. All other accelerometer outcomes were non-significant. Participants increased selfreported vigorous-intensity physical activity levels at 12 months (218 MET min/week; 6, 425), 24 months (325 MET min/week; 38, 612) and overall (148 MET min/ week; 36, 261) compared with the control group; other selfreported variables were non-significant (Table S2) .
No other differences between groups were observed for any biomedical, anthropometric, illness perception, quality of life, anxiety and depression or dietary variables (Tables S3-S6) .
Results for the primary outcome were similar for the perprotocol analysis and when missing values were imputed (Fig. 2) .
When stratified by glycaemic status, increased ambulatory activity in the intervention group was observed only for those with either impaired glucose tolerance, impaired fasting glucose or HbA 1c ≥ 42 mmol/mol (6.0%) at baseline (Fig. 2) . In this group, there was an increase of 513 steps/ day (175, 852) in total ambulatory activity compared with control at 12 months (Fig. 2) 
Discussion
This study demonstrates that a low-resource physical activity intervention for those with a high risk of Type 2 diabetes mellitus increases ambulatory activity by a modest 411 steps/ day at 12 months compared with controls when implemented within general practice, however, the results were not sustained over the longer-term. When stratified by glycaemic status, changes to ambulatory activity of 513 steps/day were observed at 12 months in individuals with dysglycaemia at baseline [impaired glucose tolerance, impaired fasting glucose or HbA 1c ≥ 42 mmol/mol (6.0%)], whereas no effect was seen in those with normoglycaemia.
This trial has several strengths including the randomized design, annual follow-up over 3 years, the objective measurement of physical activity and the primary care setting. Limitations include the amount of missing data in the primary outcome, although the results remained unaffected by a sensitivity analysis with imputed data. In addition, the method of identifying diabetes risk through a non-invasive risk score, although pragmatic, may not reflect routine clinical practice in many regions where risk is confirmed with a biochemical test, such as HbA 1c . Limitations are also inherent in using a cluster design, including an increased likelihood of differences between groups at the participant level.
The results of this study are in contrast to an earlier efficacy intervention, the PREPARE trial, which demonstrated an intervention effect of around 2000 steps/day over 12 months [8] . This finding further highlights the difficulty of translating physical activity studies into meaningful behaviour change when implemented within routine primary care or community settings, as observed previously in the UK in high-risk individuals or Type 2 diabetes mellitus [22, 23] .
This study generated some important observations that have relevance to prevention guidelines and programmes implemented within routine care pathways [24, 25] , including the recently launched NHS Diabetes Prevention Programme [25] . Those with dysglycaemia at baseline appeared more successful in changing their behaviour at 12 months. The confirmation of a higher than normal risk status during the programmes (all individuals plotted their glucose values on a risk chart) may have helped facilitate greater motivation for behaviour change. This is consistent with protection motivation theory, in which an association between perceived disease severity and the intention to be physically active in those with Type 2 diabetes mellitus has been demonstrated [26] . Others have also noted the difficulty in promoting lifestyle changes in asymptomatic individuals when the underlying condition is not perceived as serious [27] . This suggests that diabetes prevention programmes may be more successful when dysglycaemia has been confirmed with a blood test and used to help reinforce behaviour change. Conversely, interventions that include normoglycaemic individuals may need to focus on other risk factors or strategies. Diabetes prevention guidelines recommend the use of group-based interventions [24] . In the current study, 23% failed to attend the initial Walking Away structured education programme and tended to have worse indicators of health status than those did attend. In addition, only 41% attended Walking Away and all subsequent available annual follow-on maintenance sessions. These results are similar to other group-based diabetes prevention programmes implemented in real-world settings. In the American DEPLOY study, participants attended 57% of available sessions and in Finland 56% of individuals reported attending all group-based sessions in the GOAL Implementation Trial [28, 29] . These results suggest that strategies are needed to support uptake and adherence to prevention programmes implemented within routine care pathways, particularly when delivered over multiple sessions or when targeting more deprived and higher risk populations; strategies may need to integrate more personalized approaches tailored to individual levels of risk and motivation, including the option of one-to-one, mobile phone or web-based support. A follow-on study is currently testing the integration of some of these strategies within Walking Away [30] .
In conclusion, a pragmatic low-resource group-based structured education programme with pedometer use for those with a high risk of Type 2 diabetes, with previous evidence of efficacy, resulted in small increases in ambulatory activity compared with control conditions after 12 months when implemented within in a primary care setting; however, the results were not sustained over 36 months. 
Supporting Information
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